HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $10 Price Target

Arcadia Biosciences, Inc. -3.42%

Arcadia Biosciences, Inc.

RKDA

1.35

-3.42%

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Arcadia Biosciences (NASDAQ: RKDA) with a Buy and maintains $10 price target.